Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Moynihan

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
BMJ (Clinical Research Ed.)|May 27, 2010
FDA advisers to assess drug for low sexual desire in womenRay Moynihan
BMJ (Clinical Research Ed.)|August 8, 2009
US judge rules Merck won't face "punitive damages" in first Fosamax caseRay Moynihan
BMJ (Clinical Research Ed.)|April 9, 2010
American council on science and healthRay Moynihan
BMJ (Clinical Research Ed.)|April 9, 2010
Rosiglitazone, marketing, and medical scienceRay Moynihan
BMJ (Clinical Research Ed.)|June 4, 2014
Was the flu drug zanamivir a breakthrough or money for old rope?Ray Moynihan
BMJ (Clinical Research Ed.)|September 15, 2012
Reasons to be hopeful: streams of renewal in healthcareRay Moynihan
BMJ (Clinical Research Ed.)|June 22, 2012
Has novelty in healthcare gone a little stale?Ray Moynihan
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 21, 2016
Improving coverage of medical research in a changing media environmentJulia Medew, Ray Moynihan
BMJ (Clinical Research Ed.)|December 24, 2017
The Christmas gift of genetic uncertaintyChristopher Semsarian, Ray Moynihan
BMJ (Clinical Research Ed.)|April 16, 2002
Too much medicine?Ray Moynihan, Richard Smith
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|May 27, 2010
FDA advisers to assess drug for low sexual desire in womenRay Moynihan
BMJ (Clinical Research Ed.)|August 8, 2009
US judge rules Merck won't face "punitive damages" in first Fosamax caseRay Moynihan
BMJ (Clinical Research Ed.)|April 9, 2010
American council on science and healthRay Moynihan
BMJ (Clinical Research Ed.)|April 9, 2010
Rosiglitazone, marketing, and medical scienceRay Moynihan
BMJ (Clinical Research Ed.)|June 4, 2014
Was the flu drug zanamivir a breakthrough or money for old rope?Ray Moynihan
BMJ (Clinical Research Ed.)|September 15, 2012
Reasons to be hopeful: streams of renewal in healthcareRay Moynihan
BMJ (Clinical Research Ed.)|June 22, 2012
Has novelty in healthcare gone a little stale?Ray Moynihan
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 21, 2016
Improving coverage of medical research in a changing media environmentJulia Medew, Ray Moynihan
BMJ (Clinical Research Ed.)|December 24, 2017
The Christmas gift of genetic uncertaintyChristopher Semsarian, Ray Moynihan
BMJ (Clinical Research Ed.)|April 16, 2002
Too much medicine?Ray Moynihan, Richard Smith
Pageof 17